The potential role of ventricular compressive therapy

Surgical Clinics of North America

Volumn 84, Issue 1, 2004, Pages 45-59

  Gorman, Robert C ^a,b   Jackson, Benjamin M ^a   Gorman III, Joseph H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPLASTY; CLINICAL FEATURE; CLINICAL TRIAL; COMPRESSION THERAPY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DRESSLER SYNDROME; GENE EXPRESSION; HEART INFARCTION; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HUMAN; MITRAL VALVE REPLACEMENT; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STRESS; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 1242316278     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(03)00216-0     Document Type: Review

References (53)

1. 1998 Heart and stroke statistical update. Available at http://www.americanheart.org .
2. Levy D., Kenchaiah S., Larson M.G., Benjamin E.J., Kupka M.J., Ho K.K.L., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 347:2002;1397-1402.
3. Gheorghiade M., Bonow R.O. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 97:1998;282-289.
4. Eleffteriades J., Edwards R. Coronary bypass in left heart failure. Semin Thorac Cardiovasc Surg. 14:2002;125-132.
5. Grossi E.A., Goldberg J.D., LaPietra A., Ye X., Zakow P., Sussman M., et al. Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg. 122:2000;1107-1124.
6. Gillinov A.M., Wierup P.N., Blackstone E.H., Bishay E.S., Cosgrove D.M., White J., et al. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg. 122:2001;1125-1141.
7. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 341:1999;709-717.
8. Pfeffer M.A., Lamas G.A., Vaughan D., Parisi A.F., Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 319:1988;80-86.
9. Couper G.S., Bunton R.W., Birjiniuk V., DiSesa V.J., Fallon M.P., Collins J.J. Jr., et al. Relative risks of left ventricular aneurysmectomy in patients with akinetic scars versus true dyskinetic aneurysms. Circulation. 82:(Suppl IV):1990;IV248-IV256.
10. Batista R.J.V., Verde J., Nery P., Bocchino L., Talesjota M., Bjauama K.M. Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg. 64:1997;634-638.
11. Athanasuleas C.L., Stanley A.W. Jr., Buckberg G.D., Dor V., DiDonato M., Blackstone E.H. Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. RESTORE group. Reconstructive Endoventricular Surgery, Returning Torsion Original Radius Elliptical Shape to the LV. J Am Coll Cardiol. 37:2001;1199-1209.
12. Menicanti L., DiDonato M., Frigiola A., Buckberg G., Santambrogio C., Ranucci M., et al. Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration. J Thorac Cardiovasc Surg. 123:2002;1041-1050.
13. Frazier O.H., March R.J., Horvath K.A. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 341:1999;1021-1028.
14. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 81:1990;1161-1172.
15. St. John Sutton M., Pfeffer M.A., Plappert T., Rouleau J.L., Moye L.A., Dagenais G., et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. Circulation. 89:1994;68-75.
16. Olivetti G., Abbi R., Quaini F., Kajstra J., Chang W., Nitalava J.A., et al. Apoptosis in the failing human heart. N Engl J Med. 336:1997;1131-1141.
17. Spinale F.G. Matrix metalloproteinases. Circ Res. 90:2002;520-530.
18. Kang P.M., Izumo S. Apoptosis and heart failure: a critical review of the literature. Circ Res. 86:2000;1107-1113.
19. Bolognese L., Neskovic A.N., Parodi G., Cerisano G., Buonamici P., Santoro G.M., et al. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation. 106:2002;2351-2357.
20. Jackson B.M., Gorman J.H. III, St. John-Suttton M.G., Edmunds L.H. Jr., Gorman R.C. Progressive borderzone extension leads to heart failure after anteroapical myocardial infarction. J Am Coll Cardiol. 40:2002;1160-1167.
21. Narula J., Dawson M.S., Singh B.K., Amanullah A., Acio E.R., Chaudhry F.A., et al. Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy. J Am Coll Cardiol. 36:2000;1913-1918.
22. Saraste A., Pulkki K., Kallajoki M., Henriksen K., Parvinen M., Voipio-Pulkki L.M. Apoptosis in human acute myocardial infarction. Circulation. 95:1997;320-323.
23. Narula J., Haider N., Virmani R., DiSalvo T.G., Kolidgie F.D., Hajjar R.J., et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 335:1996;1182-1189.
24. Narula J., Arbustini E., Chandrashekhar Y., Schwaiger M. Apoptosis and the systolic dysfunction in congestive heart failure. The story of apoptosis interruptus and zombie myocytes. Cardiol Clin. 19:2001;113-126.
25. Wilson E.M., Moainie S.L., Baskin J.M., Lowry A.D., Deschamps A.M., Mukherjee R., et al. Region and species specific induction of matrix metalloproteinases occurs with post-myocardial infarction remodeling. Circulation. 107:2003;2857-2863.
26. Mann D.L. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 91:2002;988-998.
27. Cheng W., Kajstura J., Nitanhara J.A., Li B., Reiss K., Liu Y., et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res. 226:1996;316-327.
28. Cheng W., Li B., Kajstura J., Li P., Wolin M.S., Sonnenblick E.H., et al. Stretch induced programmed myocyte cell death. J Clin Invest. 95:1995;2247-2259.
29. Jackson B.M., Gorman J.H. III, Salgo I.S., Moainie S.L., Plappert T., St. John Sutton M.G., et al. Borderzone geometry increases wall stress after myocardial infarction: a contrast echocardiographic assessment. Am J Physiol. 284:2003;H475-H479.
30. Guccione J.M., Moonly S.M., Moustakidis P., Costa K.D., Moulton M.J., Ratcliffe M.B., et al. Mechanism underlying mechanical dysfunction in the border zone of left ventricular aneurysm: a finite element model study. Ann Thorac Surg. 71:2001;654-662.
31. Acker M.A., Hammond R.L., Mannion J.D., Salmons S., Stephenson L.W. Skeletal muscle as the potential power source for a cardiovascular pump: assessment in vivo. Science. 236:1987;324-327.
32. Kawaguchi O., Huang Y.F., Yuasa T., Shirota K., Carrington R.A., Hunyor S.N. Cardiomyoplasty reduces myocardial oxygen consumption: implications for direct mechanical compression. Ann Thorac Surg. 74:2002;1092-1096.
33. Jessup M. Dynamic cardiomyoplasty: expectations and results. J Heart Lung Transplant. 19:(Suppl 8):2000;S68-S72.
34. Moriera L.F., Bocchi E.A., Stolf N.A., Bellotti G., Jateue A.D. Dynamic cardiomyoplasty in the treatment of dilated cardiomyopathy: current results and perspectives. J Card Surg. 11:1996;207-213.
35. Carpentier A., Chachques J.C. Clinical dynamic cardiomyoplasty method and outcome. Semin Thorac Cardiovasc Surg. 3:1991;136-139.
36. Kass D.A., Baughman K.L., Pak P.H., Cho P.W., Levin H.R., Gardner T.J., et al. Reverse remodeling from cardiomyoplasty in human heart failure: external constraint versus active assist. Circulation. 91:1995;2314-2318.
37. Patel H.J., Polidori D.J., Pilla J.J., Plappert T., Kass D., St John-Sutton M., et al. Stabilization of chronic remodeling by asynchronous cardiomyoplasty in dilated cardiomyopathy: effects of a conditioned muscle wrap. Circulation. 96:1997;3665-3671.
38. Oz M.C. Passive ventricular constraint for the treatment of congestive heart failure. Ann Thorac Surg. 71:2001;185S-187S.
39. Chaudhry P.A., Mishima T., Sharov V.G., Hawkins J., Alferness C., Paone G., et al. Passive epicardial containment prevents ventricular remodeling in heart failure. Ann Thorac Surg. 70:2000;1275-1280.
40. Sabbah H., Chaudhry P., Kleber F., Konertz W. Passive mechanical containment of progressive left ventricular dilation: a surgical approach to the treatment of heart failure. J Heart Fail. 6:2000;115-120.
41. Saavedra W.F., Tunin R.S., Paolocci N., Mishima T., Suzuki G., Emala C.W., et al. Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure. J Am Coll Cardiol. 39:2002;2069-2076.
42. Power J.M., Raman J., Dornom A., Farish S.J., Burrell L.M., Tonkin A.M., et al. Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy. Cardiovasc Res. 44:1999;549-555.
43. Konertz W.F., Shapland J.E., Hotz H., Dushe S., Braun J.P., Stantke K., et al. Passive containment and reverse remodeling by a novel textile cardiac support device. Circulation. 104:(Suppl 1):2001;I270-I275.
44. Raman J.S., Hata M., Storer M., Power J.M., Buxton B.F., Alferness C., et al. The mid-term results of ventricular containment (ACORN WRAP) for end-stage ischemic cardiomyopathy. Ann Thorac Cardiovasc Surg. 7:2001;278-281.
45. Raman J.S., Power J.M., Buxton B.F., Alferness C., Hare D. Ventricular containment as an adjunctive procedure in ischemic cardiomyopathy: early results. Ann Thorac Surg. 70:2000;1124-1126.
46. Markovitz L.J., Savage E.B., Ratcliffe M.B., Bavaria J.E., Kreiner W.C., Bogen D.K., et al. Large animal model of left ventricular aneurysm. Ann Thorac Surg. 48:1989;838-845.
47. Gorman J.H. 3rd, Gorman R.C., Plappert T., Jackson B.M., Hiramatsu Y., St. John-Sutton M.G., et al. Infarct size and location determine development of mitral regurgitation in the sheep model. J Thorac Cardiovasc Surg. 115:1998;615-622.
48. Llaneras M.R., Nance M.L., Streicher J.T., Lima J.A., Savino J.S., Bogen D.K., et al. Large animal model of ischemic mitral regurgitation. Ann Thorac Surg. 57:1994;432-439.
49. Kelley S.T., Malekan R., Jackson B.M., Gorman J.H. III, Plappert T., Gorman R.C., et al. Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction. Circulation. 99:1999;135-142.
50. Moainie S.L., Guy T.S., Gorman J.H. III, Jackson B.M., Plappert T., St. John Sutton M., et al. Infarct restraint attenuates ischemic mitral regurgitation following posterolateral infarction. Ann Thorac Surg. 74:2002;444-449.
51. Guy TS IV, Moainie SL, Gorman JH III, Jackson BM, Plappert T, Enomoto Y, et al. Prevention of ischemic mitral regurgitation does not influence the outcome of remodeling after posterolateral myocardial infarction. Circulation, submitted for publication.
52. Pilla J.J., Blom A.S., Brockman D.J., Bowen F., Yuan Q., Giammarco J., et al. Ventricular constraint using the Acorn cardiac support device reduces myocardial akinetic area in an ovine model of acute infarction. Circulation. 106:(Suppl 1):2002;I207-I211.
53. Moainie S.L., Gorman J.H. III, Guy T.S., Bowen F.W. III, Jackson B.M., Plappert T., et al. An ovine model of postinfarction dilated cardiomyopathy. Ann Thorac Surg. 74:2002;753-760.